https://www.selleckchem.com/products/atn-161.html
Selective internal radiation therapy (SIRT) with yttrium-90 ( Y) resin microspheres is an established locoregional treatment option for unresectable hepatocellular carcinoma (HCC), which delivers a lethal dose of radiation to hepatic tumors, while sparing surrounding healthy tissue. DOORwaY90 is a prospective, multicenter, open-label, single arm study, designed to evaluate the safety and effectiveness of Y resin microspheres as first-line treatment in patients with unresectable/unablatable HCC. It is unique in that it is the first study
Like
Comment
Share
